Giuseppe Saglio Selected Research

Giuseppe Saglio Research Topics

Disease

142	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 10/2022 - 02/2002
34	Neoplasms (Cancer) 02/2022 - 07/2002
32	Philadelphia Chromosome 01/2021 - 02/2002
23	Leukemia 12/2019 - 06/2002
20	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 02/2021 - 02/2002
15	Blast Crisis (Blast Phase) 01/2020 - 03/2003
14	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 11/2016 - 09/2003
11	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 02/2022 - 01/2004
6	Residual Neoplasm 10/2021 - 02/2002
5	Iron Overload 01/2020 - 01/2010
5	Hematologic Neoplasms (Hematological Malignancy) 11/2017 - 09/2007
5	Multiple Myeloma 05/2017 - 01/2006
5	Chromosome Aberrations (Chromosome Abnormalities) 04/2015 - 05/2002
4	Inflammation (Inflammations) 01/2022 - 09/2007
4	Primary Myelofibrosis (Myelosclerosis) 01/2021 - 02/2014
4	Pleural Effusion (Pleural Effusions) 01/2018 - 04/2015
3	Disease Progression 01/2021 - 05/2002
3	Myeloid Leukemia (Leukemia, Myelocytic) 01/2020 - 12/2009
3	Myeloproliferative Disorders (Myeloproliferative Disorder) 03/2014 - 06/2007
2	Lymphoma (Lymphomas) 01/2021 - 06/2020
2	Aplastic Anemia (Anemia, Hypoplastic) 01/2020 - 11/2017
2	Systemic Mastocytosis 08/2019 - 01/2018
2	Wilms Tumor (Wilm's Tumor) 01/2016 - 04/2003
2	Anemia 01/2016 - 04/2010
2	Thrombosis (Thrombus) 09/2015 - 02/2014
2	Genomic Instability 04/2015 - 01/2015
2	Carcinogenesis 01/2015 - 09/2007
2	Iron Deficiencies 06/2014 - 09/2012
2	Headache (Headaches) 09/2011 - 06/2010
2	Exanthema (Rash) 09/2011 - 02/2008
2	Hypereosinophilic Syndrome (Loeffler Endocarditis) 05/2009 - 09/2007
2	Pathologic Complete Response 02/2009 - 12/2008
1	Infections 01/2022
1	COVID-19 08/2021
1	Pneumonia (Pneumonitis) 08/2021
1	Mitochondrial Diseases (Mitochondrial Disease) 10/2020
1	Hematologic Diseases (Blood Diseases) 12/2019

Drug/Important Bio-Agent (IBA)

94	Imatinib Mesylate (Gleevec)FDA Link 07/2021 - 02/2002
52	Tyrosine Kinase InhibitorsIBA 06/2022 - 03/2004
30	nilotinib FDA Link 10/2022 - 02/2008
25	Proteins (Proteins, Gene)FDA Link 01/2022 - 05/2002
21	Dasatinib (BMS 354825)FDA Link 01/2020 - 11/2006
11	bcr-abl Fusion ProteinsIBA 08/2017 - 02/2002
10	Phosphotransferases (Kinase)IBA 12/2020 - 06/2005
9	IronIBA 10/2020 - 01/2010
8	Messenger RNA (mRNA)IBA 10/2021 - 05/2002
8	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2021 - 12/2004
8	Biological ProductsIBA 12/2020 - 09/2003
8	Interferon-alpha (Interferon Alfa)IBA 08/2010 - 03/2002
6	Pharmaceutical PreparationsIBA 01/2020 - 09/2007
5	CalreticulinIBA 01/2021 - 01/2016
5	Protein Isoforms (Isoforms)IBA 11/2016 - 03/2006
4	EnzymesIBA 02/2021 - 02/2013
4	InterferonsIBA 12/2020 - 03/2003
4	Deferasirox FDA Link 10/2020 - 02/2008
4	Biomarkers (Surrogate Marker)IBA 08/2017 - 02/2009
4	AntigensIBA 08/2017 - 01/2008
4	NF-kappa B (NF-kB)IBA 10/2016 - 09/2007
3	Dihydroorotate DehydrogenaseIBA 06/2022 - 01/2021
3	DNA (Deoxyribonucleic Acid)IBA 02/2022 - 12/2008
3	ruxolitinibIBA 08/2021 - 02/2014
3	Indicators and Reagents (Reagents)IBA 01/2021 - 11/2010
3	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2017 - 03/2003
3	HepcidinsIBA 01/2016 - 04/2010
3	Transferrin Receptors (Transferrin Receptor)IBA 01/2016 - 04/2010
3	NucleophosminIBA 03/2008 - 01/2005
2	pyrimidineIBA 02/2021 - 01/2021
2	ElementsIBA 06/2020 - 12/2019
2	Oncogene Proteins (Oncogene Protein)IBA 01/2019 - 02/2006
2	Monoclonal AntibodiesIBA 08/2017 - 05/2017
2	Transcription Factors (Transcription Factor)IBA 10/2016 - 10/2003
2	Genetic Markers (Genetic Marker)IBA 06/2015 - 01/2004
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2015 - 09/2011
2	Amino Acids FDA Link 05/2012 - 06/2011
2	Thalidomide (Thalomid)FDA Link 01/2011 - 01/2006
2	Reactive Oxygen Species (Oxygen Radicals)IBA 08/2010 - 02/2004
2	Valproic Acid (Depakote)FDA LinkGeneric 03/2006 - 07/2005
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2022
1	Janus Kinase InhibitorsIBA 08/2021
1	venetoclaxIBA 03/2021
1	Dipyridamole (Persantine)FDA LinkGeneric 02/2021
1	diphenyl (biphenyl)IBA 01/2021
1	pyridineIBA 01/2021
1	ponatinibIBA 01/2021
1	Immunoglobulin G (IgG)IBA 01/2021
1	LigandsIBA 12/2020
1	Activin Receptors (Activin Receptor)IBA 12/2020
1	ferrous sulfate FDA Link 01/2020
1	eltrombopag FDA Link 01/2020
1	midostaurinIBA 08/2019
1	HematinicsIBA 01/2019

Therapy/Procedure

56	Therapeutics 02/2022 - 02/2002
5	Drug Therapy (Chemotherapy) 07/2019 - 12/2007
4	Stem Cell Transplantation 10/2015 - 12/2008
3	Immunotherapy 12/2018 - 06/2007
2	Chelation Therapy (Therapy, Chelation) 11/2017 - 01/2010
2	Aftercare (After-Treatment) 05/2016 - 01/2004
2	Molecular Targeted Therapy 01/2015 - 06/2010
1	Complementary Therapies (Alternative Medicine) 12/2020
1	Homologous Transplantation 12/2020